Xapit (parecoxib)
- Region
- 🇪🇺 EU
- Active substance
- parecoxib
- Company
- Pharmacia Europe EEIG
- Status
- Withdrawn
- Therapeutic area
- Pain, Postoperative
- EU approval
- Fri 22 Mar 2002
- Application
- EMEA/H/C/000380
- ATC
- M01AH04
- Official record
- www.ema.europa.eu
Indication
For the short-term treatment of postoperative pain.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Dynastat Authorised · Pfizer Europe MA EEIG
- 🇪🇺 Rayzon Withdrawn · Pharmacia Europe EEIG
Follow Xapit
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.